Vaishali Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
For the nine months, sales was INR 428.53 million compared to INR 499.79 million a year ago. Revenue was INR 451.24 million compared to INR 516.5 million a year ago. Net income was INR 61.67 million compared to INR 38.21 million a year ago. Basic earnings per share from continuing operations was INR 5.85 compared to INR 3.62 a year ago. Diluted earnings per share from continuing operations was INR 5.85 compared to INR 3.62 a year ago.